Wolters Kluwer Health announces that KLAS Research has recognized Sentri7® clinical surveillance solutions as Best in KLAS® for both Pharmacy Surveillance as well as Infection Control and Monitoring in the 2026 Best in KLAS – Software and Services report released today. KLAS Research, which specializes in monitoring and reporting the performance of healthcare solution providers, rated the evidence-based Sentri7 solutions as market leaders for hospitals seeking to optimize infection prevention (IP) programs and hospital pharmacy performance.
End-to-end clinical surveillance & medication management
The Wolters Kluwer Sentri7 suite offers a single-platform approach to deliver comprehensive clinical surveillance and medication management. With real-time patient identification, clinicians can save time by prioritizing at-risk patients and intervening earlier. Sentri7 Pharmacy Surveillance helps pharmacy leaders improve hospital performance, not only to lower medication use and costs, but also to decrease risk and mortality. Hospital pharmacies turn to Sentri7 as a key tool for enhancing patient care, safety, and satisfaction, and it has notably influenced patient outcomes and operational efficiency.
Sentri7 Infection Prevention optimizes programs by speeding up identification of healthcare-acquired infections (HAIs) and emerging trends. Its advanced capabilities empower care teams to enhance quality, reduce costs, and improve patient outcomes. Additionally, Sentri7 simplifies regulatory reporting, allowing healthcare professionals to focus on what matters most—delivering exceptional patient care.
